Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Immucell (ICCC) Accumulated Depreciation & Amortization (2016 - 2025)

Immucell (ICCC) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Depreciation & Amortization rose 1.43% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2025, up 1.43%, and an annual FY2024 reading of $2.7 million, changed 0.36% over the prior year.
  • Accumulated Depreciation & Amortization was $2.1 million for Q3 2025 at Immucell, down from $2.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $19.1 million in Q1 2024 and bottomed at $2.0 million in Q3 2024.
  • Average Accumulated Depreciation & Amortization over 5 years is $12.1 million, with a median of $14.3 million recorded in 2021.
  • The sharpest move saw Accumulated Depreciation & Amortization grew 20.03% in 2021, then crashed 88.52% in 2024.
  • Year by year, Accumulated Depreciation & Amortization stood at $14.0 million in 2021, then grew by 13.45% to $15.9 million in 2022, then tumbled by 82.74% to $2.7 million in 2023, then decreased by 0.36% to $2.7 million in 2024, then decreased by 24.01% to $2.1 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for ICCC at $2.1 million in Q3 2025, $2.7 million in Q4 2024, and $2.0 million in Q3 2024.